Οκτ 28, 2015 | Announcements, Conferences - Seminars, Events
Hellenic Pulmonary Hypertension together with seventy-one pulmonary hypertension patient leaders from 30 countries took part in the 2015 edition of the APHEC. The program started with the Annual General Assembly, the elections for the new Board and Auditors, and the...Σεπ 15, 2015 | Announcements, Medical News, Scientific articles
By Patricia Silva, PhD A study led by researchers at the Imperial College London in the United Kingdom was recently published in the journal Nature reporting the discovery of a gene involved in pulmonary hypertension pathology. The study is entitled “The zinc...Σεπ 14, 2015 | Announcements, Medical News, Scientific articles
By Patricia Silva, PhD Gilead Sciences, Inc. recently announced the publication of data in The New England Journal of Medicine concerning the AMBITION trial evaluating the combination therapy of Letairis® (ambrisentan) and tadalafil for pulmonary arterial...Σεπ 12, 2015 | Announcements, Medical News, Scientific articles
By Maureen Newman The recent announcement of positive results for the AMBITION trial testing combinatorial ambrisentan and tadalafil in patients with pulmonary arterial hypertension (PAH) is bringing more attention to the need to actively recruit participants for...Σεπ 10, 2015 | Announcements, Medical News, Scientific articles
By Patricia Inacio, PhD In a new study entitled “Symptom Interference Severity and Health-Related Quality of Life in Pulmonary Arterial Hypertension,” researchers determined which symptoms experienced by those with pulmonary arterial hypertension are the most...Σεπ 9, 2015 | Announcements, Medical News, Scientific articles
By Christine Traxler, MD An 18 year-long prospective study on the length of television watching and the risk of pulmonary embolism revealed a positive correlation between the length of time a person watches television per day and the risk of developing a possibly...
Join our mailing list to receive the latest news and updates from our team.